Vaccine against cervical cancer most effective in 10- to 14-year-olds
20th Dec 2005, 05:26 GMT
Cervarix, a vaccine that protects against cervical cancer caused by the human papilloma virus (HPV), is the most effective when administered to girls between the ages of 10 to 14 years, its maker GlaxoSmithKline (GSK) said in Washington while presenting the results of the phase III trials of the vaccine.
Vaccine against cervical cancer most effective in 10- to 14-year-olds related news:
- Cervical cancer vaccine trials encouraging — OnMedica Latest News
- Good results with cervical cancer vaccine in young girls — News-Medical News Feed
- Cancer vaccine has strong response in young girls — KeralaNext: Health
- ERVARIX(tm), GSK's Cervical Cancer Vaccine Candidate Induced A Higher Immune Response In 10-14 Year-Old Girls Versus 15-25 Year-Old Young Women — Medical News Today RSS/XML Feed
- Cervial cancer vaccine doubly effective in young girls — KeralaNext: Health
- Fears on Cancer Vaccine for Girls — RedOrbit News - Health
- Cancer vaccine more active in girls - study — IOL: SciTech
- GSK HPV Vaccine Produces Stronger Immune Response In Girls Ages 10 - 14 Than In Older Women — Medical News Today RSS/XML Feed
- Cervical cancer screening failure linked to poverty — WebWire - Recent Headlines
- The Pill doesn't affect cervical pre-cancer risk (Reuters) — Yahoo! News: Health News
Latest news from The Earth Times Online Newspaper - Health News:
- Senior citizens to choose their prescription drug plan
- Children showing signs of hardening of arteries, says study
- Sisters lose their stomachs to get a life
- Speeding up the ER triage for heart attack patients
- Study says waltzing good for heart health
- Painkiller substance discovered in human saliva
- Red meat - cancer nexus
- Flu drug Tamiflu causing abnormal behavior
- Botox away your Osteoarthritis blues?
- Study suggests that maternal diet during pregnancy may affect generations